Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for RRMM Patients (MAPLE)
Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for RRMM Patients (MAPLE)
Not yet recruiting · NCT07831122 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for RRMM Patients (MAPLE) | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 1 | 2026-09-21 | NCT07831122 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Myeloma Research Group | 4 |
| GlaxoSmithKline | 294 |
| Hoffmann-La Roche | 280 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cross Cancer Institute | Edmonton | Canada | 146 |
| Hospital Maisonneuve - Rosemont | Montreal | Canada | 1 |
| London Health Sciences Centre | London | Canada | 58 |
| McGill University Health Centre -MUHC | Montreal | Canada | 1 |
| QEII Health Sciences Centre | Halifax | Canada | 7 |
| The Ottawa Hospital - General Hospital | Ottawa | Canada | 1 |
| UHN-Princess Margaret Cancer Centre | Toronto | Canada | 1 |